Approved Study Database

Ref. No. Scientific Title Principal investigator
2013.515 A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg-Positive, Chronic Hepatitis B Dr. YIP Wai Man
2013.514 A Randomized, Double-Blind, Parallel-Group, Placebo- and Active- Controlled, Multi-center Study to Evaluate the Efficacy, Safety and Tolerability of Combinations of Solifenacin Succinate and Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in the Treatment of Overactive Bladder Dr. CHAN Symphorosa Shing Chee
2013.509 The investigation of healing effects of topically applied autologous adipose-derived mesenchymal stem cells and herbal drink mixture of Radix Astragali and Radix Rehmanniae on chronic wounds Dr. CHENG Sally Hi Shan
2013.504 A double-blind, placebo-controlled study of N-acetylcysteine for ketamine dependence Prof Tang Wai Kwong
2013.495 A prospective randomized comparative study of open and percutaneous release of acquired trigger thumb Dr. TSE Wing Lim
2013.494 PROSPER: A Multinational, Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer Prof. NG Chi Fai
2013.493 A Double-blind, Randomized, Placebo-Controlled Study Evaluating the Safety and Effectiveness of Cook MyoSite Incorporated AMDC in Female Patients with Stress Urinary Incontinence Prof Ng Chi Fai
2013.490 A Prospective, Randomized, Open-Label Comparison of a Long-Acting Basal Insulin Analog, LY2963016, to Lantus® in Combination with Mealtime Insulin Lispro in Adult Patients with Type 1 Diabetes Mellitus: The ELEMENT 3 Study Dr. Ozaki Risa
2013.483 A randomized, open label, phase II study: stereotactic body radiotherapy (SBRT) vs conventional intensity-modulated radiotherapy (IMRT) for low or intermediate risk prostate cancer in Asia population Dr. POON Ming Chun
2013.482 Oral Arsenic trioxide in Management of Newly Diagnosed and Relapsed or refractory Acute Promyelocytic Leukemia (PML/RARα) in Children Dr. LI Chi Kong
2013.474 A Phase 3, Randomized, Double-blind, Controlled Study of Cabozantinib (XL184) vs Placebo in Subjects with Hepatocellular Carcinoma Who Have Received Prior Sorafenib Dr. CHAN Stephen Lam
2013.470 A multi-center, uncontrolled extension study evaluating efficacy and safety of SAR153191 on top of DMARDs in patients with active Rheumatoid Arthritis (RA) Prof Tam Lai Shan
2013.461 A multicenter, open-label, randomized phase II study to evaluate the efficacy of AUY922 vs pemetrexed or docetaxel in NSCLC patients with EGFR mutations who have progressed on prior EGFR TKI treatment Prof. MOK Tony Shu Kam
2013.460 An open label, multicentre, single-arm trial to assess the safety of afatinib for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring EGFR mutation(s) Dr. LAM Kwok Chi
2013.449 The impact on platelet inhibitory effect with concurrent use of Proton Pump Inhibitors and clopidogrel Prof. CHAN Francis
2013.445 SINGLE-SITE, OPEN-LABEL, RANDOMIZED, CROSS-OVER STUDY IN HEALTHY CHINESE SUBJECTS TO EVALUATE THE BIOEQUIVALENCE OF SINGLE-DOSE ROTIGOTINE TRANSDERMAL PATCH (2MG/24H) COMPARING 2 DIFFERENT FORMULATIONS Prof Tomlinson Brian
2013.440 The effect of a father inclusive psychoeducation program on postnatal depression: a randomized controlled trial Ms. Wong Suk Man
2013.430 AN OPEN-LABEL BOSUTINIB TREATMENT EXTENSION STUDY FOR SUBJECTS WITH CHRONIC MYELOID LEUKEMIA (CML) WHO HAVE PREVIOUSLY PARTICIPATED IN BOSUTINIB STUDIES B1871006 OR B1871008 Dr. WONG Raymond Siu Ming
2013.427 A prospective, single-arm, multicenter, uncontrolled, open-label Phase II trial of refametinib (BAY 86-9766) in patients with RAS mutant Hepatocellular Carcinoma(HCC) Prof Yeo Winnie
2013.421 A pilot study evaluating the safety, feasibility and efficacy of catheter-based paravalvular leaks closure in patients who are not suitable for open heart surgery Associate Professor Lam Yat Yin
2013.420 Transcatheter Renal Denervation with an over-the-wire balloon based technology for Patiemts with Resistant Hypertension Prof. YAN Bryan Ping Yen
2013.414 Effect of an infant formula containing partially hydrolyzed protein, high sn-2 palmitate and reduced lactose in unsettled infants experiencing feeding intolerance Prof. HON Kam Lun, Ellis
2013.413 A Pilot Study of the Effectiveness of a Novel Herbal Bath for the Treatment of Acute Ankle Sprain Injury Prof. Hung Leung Kim
2013.410 A Phase 3b, Multicenter, Open-Label, Randomized Study to Investigate the Efficacy and Safety of Sofosbuvir plus Ribavirin in Treatment-Na_ve Subjects with Chronic Genotype 1, 2, 3 and 6 HCV Infection and in Treatment-Experienced Subjects with Chronic Genotype 2 HCV Infection Prof. CHAN Henry Lik Yuen
2013.409 Efficacy and safety of semaglutide once-weekly versus sitagliptin once-daily as add-on to metformin and/or TZD in subjects with type 2 diabetes Dr. CHOW Francis Chun Chung
2013.407 Pharmacokinetic study of once-daily formulation of Tacrolimus (Advagraf_) in Chinese kidney transplant patients Dr Ma King Wing, Terry
2013.400 The effect of diabetic foot care education self-efficacy and foot care behavior in people with diabetes: A randomized control trial Ms. CHAN Ellen Yee Lun
2013.395 A prospective multicentre study assessing the utility of Narrow Band Imaging with dual focus magnification in differentiating colorectal neoplasia using the NICE and Modified Sano's Classification Prof. LAU James Y.W.
2013.392 A phase Ib trial of LEE011 in combination with everolimus (RAD001) and exemestane in the treatment of postmenopausal women with hormone receptor positive HER2 negative locally advanced or metastatic breast cancer Prof. MA Brigette Buig Yue
2013.375 Pathophysiology of oropharyngeal dysphagia in post-irradiation nasopharyngeal carcinoma patients in relation to penetration-aspiration - A pilot study Mr CHENG Dennis Tze-ho
2013.374 Safety and tumoricidal effect of low dose temoporfin photodynamic therapy in patients with inoperable bile duct cancers (Foscan study) Prof. LAU James Y.W.
2013.370 A PILOT STUDY ON THE EFFECTIVENESS OF A NOVEL HERBAL PATCH FOR THE TREATMENT OF PLANTAR FASCIITIS HUNG Leung-kim
2013.362 Curcumin Add-on Therapy for Induction of Remission in Mild-to-Moderate Ulcerative Colitis: A Prospective, Randomized, Placebo-Controlled, Double-Blind Study Prof Ng Siew Chien
2013.360 Dinoprostone vaginal extended release system (Propess) for induction of labour versus amniotomy plus syntocinon, a randomized controlled trial Prof. LEUNG Tak Yeung
2013.358 A controlled study of the benefits of an aerobic exercise programme in psychiatric outpatients on treatment for depression in Hong Kong Dr Cheung Lap Kei
2013.351 Effect of Heparin on Radial Artery Occlusion After Transradial Artery Catheterization for Coronary Angiography. Professor YAN Bryan
2013.346 Endoscopic ultrasonography-guided biliary access in patients with failed common bile duct cannulation after endoscopic retrograde cholangiopancretography. Dr. TEOH Anthony Yuen Bun
2013.345 Clinical Bioequivalence Study on Two Crotamiton Cream Formulations Prof. LEE Vincent Hon Leung
2013.338 A phase II trial of PEG-BCT-100 as the second-line therapy following sorafenib in patients with advanced hepatocellular carcinoma Dr. CHAN Stephen Lam
2013.328 A pilot study on effectiveness of self-efficacy based educational programme on maternal breastfeeding self-efficacy and breastfeeding duration: A longitudinal, randomized controlled study. Ms Chan Man Yi
2013.319 REstrictive versus LIbEral Fluid Therapy in Major Abdominal Surgery (RELIEF) Trial Dr. CHAN Matthew Tak Vai
2013.316 A randomized controlled trial of a new screening strategy for varices based on liver and spleen stiffness measurement (LSSM) in cirrhotic patients Dr. WONG Grace Lai Hung
2013.305 Percutaneous Left Atrial Appendage Closure by LAmbre device for Stroke Prevention in High-risk Atrial Fibrillation Dr. CHAN Anna Kin Yin
2013.296 A Phase 2/3, Multi-Center, Open Label Study of Efficacy, Safety, and Pharmacokinetics of PEGylated Recombinant Factor VIII (BAX855) Administered for Prophylaxis and Treatment of Bleeding in Previously Treated Patients with Severe Hemophilia A Dr. Wong Siu Ming Raymond
2013.295 LUX-Head & Neck 3: A randomized, open label, phase III study to evaluate the efficacy and safety of oral afatinib (BIBW 2992) versus intravenous methotrexate in patients with recurrent and / or metastatic head and neck squamous cell carcinoma who have progressed after platinum-based therapy. Prof. CHAN Anthony Tak Cheung
2013.294 A phase Ib/II, open-label study of LJM716 in combination with BYL719 compared to taxane or irinotecan in patients with previously treated esophageal squamous cell carcinoma Prof. MA Brigette Buig Yue
2013.293 A randomized, double-blind, placebo-controlled, multi-center study to assess the safety and efficacy of different oral doses of BAY 94-8862 in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic nephropathy Dr. OZAKI Risa
2013.283 Biomechatronic System Using Electromyography (EMG)-driven Neuromuscular Electrical Stimulation (NMES) for Upper Limb Rehabilitation Prof. POON Wai Sang
2013.282 A Phase III, Randomized Clinical Trial to Study the Safety and Efficacy of MK-906 (Finasteride) and Tamsulosin Administered Either Alone or Concomitantly in Patients with Benign Prostatic Hyperplasia (BPH) Professor Ng Chi-Fai
2013.275 The effect of a health promotion program on health outcomes and health-promoting behavior of individuals with metabolic syndrome: a randomized controlled trial Ms Lo Wai Sze

Page 226 of 263.